Bradley Pharmaceuticals names Thomas Rispoli as Director of Managed Care Administration & Finance.

FAIRFIELD, NJ--(BUSINESS WIRE)--Dec. 1, 1995--BRADLEY PHARMACEUTICALS, INC. (NASDAQ NM: BPRXA) announced today that it has named Thomas Rispoli to the post of Director of Managed Care Administration & Finance. This newly created position is designed to insure efficient management and control of the Company's managed care business and all associated costs.

Mr. Rispoli will head an expanded managed care financial control department, and will report directly to Alan V. Gallantar, V.P. Chief Financial Officer of Bradley Pharmaceuticals. In his capacity as Director of Managed Care Administration & Finance, Mr. Rispoli will be working in tandem with the firm's managed care marketing arm, headed by Robert Dubin, R. Ph., National Director, Managed Care. "We needed a specialist to fill this position...someone who could handle the financial segment of our managed care business. We also needed someone who could work hand-in-hand with the marketing department to ensure that the two departments functioned as partners, and we think Tom Rispoli is the perfect fit," said Alan V. Gallantar, Bradley's V.P. and CFO.

Daniel Glassman, Chairman and CEO of Bradley Pharmaceuticals, states "The appointment of Mr. Rispoli is part of an ongoing plan to upgrade operations to accommodate the Company's revenue and expenditures in regard to managed care sales. With the reorganization of both the managed care financial and marketing departments, I believe that we have put into place the necessary personnel and systems to manage this part of our business."

Mr. Rispoli comes to Bradley Pharmaceuticals from Reed & Carnrick where he had served as Manager, Bids and Contracts. During his 19 year career at Reed & Carnrick, Mr. Rispoli developed considerable expertise in the field of managed care contracts and invoicing which he will now use on behalf of Bradley.

BRADLEY PHARMACEUTICALS, INC. markets and manufactures brandname prescription and over-the-counter pharmaceutical and health-related products, including respiratory, dermatologic, nutrition, personal hygiene and internal medicine brands. Bradley Common Class A Shares, and Bradley Class A, B, and D Warrants (BPRXA, BPRXW, BPRXZ and BPRXL, respectively) are traded on the Nasdaq National Market System.

CONTACT: Alan V. Gallantar

V.P. Chief Financial Officer

Bradley Pharmaceuticals, Inc.

[phone] Ext. 266